Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice

J Cell Biochem. 2012 Jan;113(1):141-7. doi: 10.1002/jcb.23337.

Abstract

Proton pump inhibitors (PPIs) are widely used against gastroesophageal reflux disease. Recent epidemiological studies suggest that PPI users have an increased risk of fractures, but a causal relationship has been questioned. We have therefore investigated the skeletal phenotype in H(+) /K(+) ATPase beta-subunit knockout (KO) female mice. Skeletal parameters were determined in 6- and 20-month-old KO mice and in wild-type controls (WT). Whole body bone mineral density (BMD) and bone mineral content (BMC) were measured by dual energy X-ray absorptiometry (DXA). Femurs were examined with µCT analyses and break force were examined by a three-point bending test. Plasma levels of gastrin, RANKL, OPG, osteocalcin, leptin, and PTH were analyzed. KO mice had lower whole body BMC at 6 months (0.53 vs. 0.59 g, P = 0.035) and at 20 months (0.49 vs. 0.74 g, P < 0.01) compared to WT as well as lower BMD at 6 months (0.068 vs. 0.072 g/cm(2) , P = 0.026) and 20 months (0.067 vs. 0.077 g/cm(2) , P < 0.01). Mechanical strength was lower in KO mice at the age of 20 months (6.7 vs. 17.9 N, P < 0.01). Cortical thickness at 20 months and trabecular bone volume% at 6 months were significantly reduced in KO mice. Plasma OPG/RANKL ratio and PTH was increased in KO mice compared to controls. H(+) /K(+) ATPase beta subunit KO mice had decreased BMC and BMD, reduced cortical thickness and inferior mechanical bone strength. Whereas the mechanism is uncertain, these findings suggest a causal relationship between long-term PPI use and an increased risk of fractures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorptiometry, Photon / methods
  • Animals
  • Bone Density / genetics*
  • Bone and Bones / pathology*
  • Female
  • Fractures, Bone / chemically induced
  • Gastrins / blood
  • Leptin / blood
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Mitochondrial Proton-Translocating ATPases / deficiency*
  • Mitochondrial Proton-Translocating ATPases / genetics*
  • Osteocalcin / blood
  • Osteoprotegerin / blood
  • Parathyroid Hormone / blood
  • Protein Subunits / deficiency
  • Protein Subunits / genetics
  • Proton Pump Inhibitors / adverse effects
  • Proton Pump Inhibitors / therapeutic use
  • RANK Ligand / blood
  • Risk

Substances

  • Gastrins
  • Leptin
  • Osteoprotegerin
  • Parathyroid Hormone
  • Protein Subunits
  • Proton Pump Inhibitors
  • RANK Ligand
  • Tnfrsf11b protein, mouse
  • Tnfsf11 protein, mouse
  • Osteocalcin
  • Mitochondrial Proton-Translocating ATPases